TABLE 3.
Drug use history and current injection practices among suburban injectors by status of chronic pain in Connecticut, 2008–2012
| Drug use | Chronic Pain (n = 143) | No Chronic Pain (n = 313) | p-value1 |
|---|---|---|---|
| Duration of Injection, mean ± s.d., median & IQR | 14.7 ± 12.2, 10.0, 21.0 | 9.4 ± 8.8, 6.0, 11.0 | <.0001 |
| Frequency of Injection, last 30 days, mean ± s.d., median & IQR2 | 87.9 ± 223.4, 29.0, 57.0 | 63.2 ± 107.3, 34.0, 68.0 | 0.18 |
| Heroin as drug of choice | 88.8% | 91.0% | 0.46 |
| Heroin as drug most commonly injected, last 30 days | 82.1% | 86.8% | 0.31 |
| Injection of Pharmaceutical Opioids | |||
| Ever | 48.3% | 36.7% | 0.02 |
| Last 30 days | 16.8% | 13.7% | 0.39 |
| Injection Risk | |||
| Syringe Sharing | 25.2% | 20.5% | 0.26 |
| Paraphernalia Sharing | 43.4% | 36.7% | 0.18 |
| Sharing of Dissolved Drugs | 22.6% | 20.5% | 0.70 |
| Overdose | |||
| Ever | 37.1% | 27.6% | 0.04 |
| Number of ODs (lifetime)2 | 1.0 ± 1.9, 0.0, 2.0 | 0.7 ± 1.8, 0.0, 1.0 | 0.03 |
| OD last Year | 21.7% | 23.5% | 0.82 |
| OD Knowledge | 58.0 ± 15.8, 57.1, 14.3 | 60.4 ± 17.8, 64.3, 21.4 | 0.16 |
| Serology | |||
| HIV3 | 1.4% | 1.7% | 1.00 |
| HCV | 44.3% | 39.2% | 0.31 |
| HBV | 0.03 | ||
| Never infected | 45.7% | 43.7% | |
| Vaccinated | 23.6% | 34.7% | |
| Infected | 30.7% | 21.7% |
1)
Without specific notes, p-value was obtained using chi-square test for categorical variables and t-test for continuous variables.
2)
P-value was obtained using t-test on log-transformed variable.
3)
P-value was obtained using Fisher’s exact test.